Your browser doesn't support javascript.
loading
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial.
Goll, G L; Jørgensen, K K; Sexton, J; Olsen, I C; Bolstad, N; Haavardsholm, E A; Lundin, K E A; Tveit, K S; Lorentzen, M; Berset, I P; Fevang, B T S; Kalstad, S; Ryggen, K; Warren, D J; Klaasen, R A; Asak, Ø; Baigh, S; Blomgren, I M; Brenna, Ø; Bruun, T J; Dvergsnes, K; Frigstad, S O; Hansen, I M; Hatten, I S H; Huppertz-Hauss, G; Henriksen, M; Hoie, S S; Krogh, J; Midtgard, I P; Mielnik, P; Moum, B; Noraberg, G; Poyan, A; Prestegård, U; Rashid, H U; Strand, E K; Skjetne, K; Seeberg, K A; Torp, R; Ystrøm, C M; Vold, C; Zettel, C C; Waksvik, K; Gulbrandsen, B; Hagfors, J; Mørk, C; Jahnsen, J; Kvien, T K.
Afiliação
  • Goll GL; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.
  • Sexton J; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Olsen IC; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Bolstad N; Research Support Services CTU, Oslo University Hospital, Oslo, Norway.
  • Haavardsholm EA; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Lundin KEA; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Tveit KS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Lorentzen M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Berset IP; Department of Gastroenterology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Fevang BTS; K.G. Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway.
  • Kalstad S; Department of Dermatology, Haukeland University Hospital, Bergen, Norway.
  • Ryggen K; Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Warren DJ; Department of Gastroenterology, Ålesund Hospital, Ålesund, Norway.
  • Klaasen RA; Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
  • Asak Ø; Department of Rheumatology, University Hospital of Northern Norway, Tromsø, Norway.
  • Baigh S; Department of Dermatology, Sankt Olav's Hospital, Trondheim, Norway.
  • Blomgren IM; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Brenna Ø; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
  • Bruun TJ; Department of Gastroenterology, Gjøvik Hospital, Gjøvik, Norway.
  • Dvergsnes K; Department of Dermatology, Haugesund Hospital, Haugesund, Norway.
  • Frigstad SO; Department of Gastroenterology, Haugesund Hospital, Haugesund, Norway.
  • Hansen IM; Department of Gastroenterology, Sankt Olav's Hospital, Trondheim, Norway.
  • Hatten ISH; Department of Rheumatology, University Hospital of Northern Norway, Tromsø, Norway.
  • Huppertz-Hauss G; Department of Gastroenterology, Sørlandet Hospital, Kristiansand, Norway.
  • Henriksen M; Department of Gastroenterology, Baerum Hospital, Baerum, Norway.
  • Hoie SS; Department of Rheumatology, Helgelandssykehuset, Mo I Rana, Norway.
  • Krogh J; Department of Dermatology, Førde Hospital, Førde, Norway.
  • Midtgard IP; Department of Gastroenterology, Telemark Hospital, Skien, Norway.
  • Mielnik P; Department of Gastroenterology, Østfold Hospital, Fredrikstad, Norway.
  • Moum B; Department of Rheumatology, Sørlandet Hospital, Kristiansand, Norway.
  • Noraberg G; Department of Rheumatology, Levanger Hospital, Levanger, Norway.
  • Poyan A; Department of Rheumatology, Bodø Hospital, Bodø, Norway.
  • Prestegård U; Department of Rheumatology, Førde Hospital, Førde, Norway.
  • Rashid HU; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Strand EK; Department of Gastroenterology, Oslo University Hospital Ullevål, Oslo, Norway.
  • Skjetne K; Department of Gastroenterology, Sørlandet Hospital, Arendal, Norway.
  • Seeberg KA; Department of Rheumatology, Kongsvinger Hospital, Kongsvinger, Norway.
  • Torp R; Department of Gastroenterology, Lillehammer Hospital, Lillehammer, Norway.
  • Ystrøm CM; Department of Rheumatology, Østfold Hospital, Moss, Norway.
  • Vold C; Department of Rheumatology, Revmatismesykehuset, Lillehammer, Norway.
  • Zettel CC; Department of Dermatology, Sankt Olav's Hospital, Trondheim, Norway.
  • Waksvik K; Department of Gastroenterology, Vestfold Hospital, Tønsberg, Norway.
  • Gulbrandsen B; Department of Gastroenterology, Hamar Hospital, Hamar, Norway.
  • Hagfors J; Department of Gastroenterology, Elverum Hospital, Elverum, Norway.
  • Mørk C; Department of Gastroenterology, Bodø Hospital, Bodø, Norway.
  • Jahnsen J; Department of Rheumatology, Betanien Hospital, Skien, Norway.
  • Kvien TK; Patient representative, Norges Psoriasis- og eksemforbund, Trondheim, Norway.
J Intern Med ; 285(6): 653-669, 2019 06.
Article em En | MEDLINE | ID: mdl-30762274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite / Psoríase / Colite Ulcerativa / Infliximab / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite / Psoríase / Colite Ulcerativa / Infliximab / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega